GlassScriptPhysician profile
Daniel H Fleischman
NPI 1568729069
$3,382.57
in general payments reported to CMS, 2019-2025
3 companies · $591 in 2025
The $591 reported for 2025 was more than what 80% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $209 · 2021: $741 · 2022: $688 · 2023: $175 · 2024: $571 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $775 · Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $775.00 |
| Food and Beverage | $561.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,171.72 | 2019-2025 | |
| Nobel Biocare USA | $189.21 | 2019-2020 | |
| Ss White Burs LLC | $21.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.